Award
NIH Reporter #3U01AI172853-04S1
Development of a Novel Therapeutic for Mitigating Radiation-Induced Microbiome Dysbiosis and Acute Gastrointestinal Syndrome
Recipient
Columbia University Health Sciences
Award Amount
$89,415.00
Ceiling
$89,415.00
Awarded
August 18, 2026
Identifier
3U01AI172853-04S1
Award for developing a novel therapeutic to mitigate radiation-induced gastrointestinal injury and microbiome dysbiosis, including studying its effects and mechanisms for FDA approval.
Description
This project focuses on developing a therapeutic agent (MIIST305) to mitigate gastrointestinal injury caused by radiation exposure, with aims to study its effects on microbiome and inflammation, and mechanisms of action for FDA approval.